Interferon tiloron inductor usage in complex therapy at patients with community-acquired pneumonia

The article presents the research findings concerning the importance of changes of the contents in blood serum of interferon gamma (INF -γ), interferon alfa (INF -α), the tumor necrosis factor alfa (TNF -α), interleukin 4 (IL -4), interleukin8 (IL -8) and clinical parameters at patients with community-acquired pneumonia before the end of treatment (basic therapy and with immunomodulator tiloron). Tiloron positive influence on clinical manifestations and immunological parameters (profile of cytokines- IL -4, IL -8, INF -α, INF -γ and INF -α) has been detected in patients with slightly complicated community-acquired pneumonia in 95 % of cases.